Brightgene Bio-Medical Technology Co.,Ltd. News

Announcement on Voluntary Disclosure of Phase II Clinical Trial Data on BGM0504 Injection Weight Loss Indications

Oct 13 12:00 ET

Convertible debt-to-equity conversion results and share change announcement

Oct 8 12:00 ET

Announcement on the election of the chairman, members of the special committee of the board of directors, the chairman of the board of supervisors, and the appointment of senior management and representatives of securities affairs

Sep 27 12:00 ET

Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on the 2024 First Extraordinary General Meeting of Shareholders of Borui Biopharmaceuticals (Suzhou) Co., Ltd.

Sep 27 12:00 ET

Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders

Sep 27 12:00 ET

Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders

Sep 18 12:00 ET

Announcement on additional provisional proposals for the 2024 First Extraordinary General Meeting of Shareholders

Sep 18 12:00 ET

Announcement on capital increase and stock expansion of holding subsidiaries and related transactions

Sep 18 12:00 ET

Announcement on changes in implementing entities for some fund-raising projects

Sep 18 12:00 ET

Announcement on providing guarantees for wholly-owned subsidiaries to carry out financial leasing business

Sep 18 12:00 ET

Notice on holding the 2024 First Extraordinary General Meeting of Shareholders

Sep 11 12:00 ET

Announcement on not revising the conversion price of “Borui Bonds” downwards

Aug 27 12:00 ET

Announcement on voluntary disclosure of BGM0504 injection phase II clinical trial data for type 2 diabetes

Aug 26 12:00 ET

Announcement regarding the receipt of a notice of acceptance of a civil application for retrial.

Aug 23 12:00 ET

Announcement regarding the change of business scope and amendment of the company's articles of association.

Aug 23 12:00 ET

Announcement regarding the election of the board of directors and the board of supervisors.

Aug 23 12:00 ET

Notice for the expected satisfaction of the conversion price adjustment conditions for Borui convertible bonds.

Aug 20 12:00 ET

Announcement of convertible bonds conversion results and share changes.

Jul 1 12:00 ET

Announcement regarding the addition of new implementation entities for some funded projects.

Jun 25 12:00 ET

Announcement regarding the debt-for-equity swaps conversion price adjustment for the 2023 annual equity distribution of convertible bonds.

Jun 25 12:00 ET